Michael J Kovacs Selected Research

Tinzaparin (Innohep)

4/2005

A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J Kovacs Research Topics

Disease

34	Venous Thromboembolism 11/2023 - 02/2003
19	Hemorrhage 01/2023 - 07/2003
14	Pulmonary Embolism 01/2023 - 07/2003
13	Venous Thrombosis (Deep-Vein Thrombosis) 07/2022 - 07/2003
11	Thrombosis (Thrombus) 01/2021 - 05/2003
7	Neoplasms (Cancer) 11/2023 - 07/2003
7	Thrombophilia 01/2023 - 07/2007
6	Multiple Myeloma 02/2015 - 12/2004
5	Thromboembolism 01/2021 - 07/2003
4	Thrombocytopenia (Thrombopenia) 02/2015 - 05/2003
3	Edema (Dropsy) 01/2021 - 08/2008
3	Hyperpigmentation 01/2021 - 08/2008
2	Obesity 01/2021 - 03/2017
2	Body Weight (Weight, Body) 02/2018 - 07/2003
2	Dyspnea (Shortness of Breath) 01/2017 - 02/2013
2	Pregnancy Complications 11/2014 - 07/2007
1	Upper Extremity Deep Vein Thrombosis 11/2023
1	Postthrombotic Syndrome 07/2022
1	Atrial Fibrillation 01/2021
1	Abruptio Placentae (Placental Abruption) 01/2018
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 11/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2014
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 04/2014
1	Hypesthesia (Numbness) 02/2013
1	Constipation 02/2013
1	Second Primary Neoplasms (Neoplasms, Second) 02/2013
1	Neovascular Glaucoma 09/2010
1	Retinal Vein Occlusion 09/2010
1	Hypertension (High Blood Pressure) 07/2007
1	Fatigue 05/2005
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2004
1	Eosinophilia 07/2004
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 07/2004
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2003
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2003
1	Febrile Neutropenia 05/2003

Drug/Important Bio-Agent (IBA)

25	AnticoagulantsIBA 11/2023 - 07/2003
14	Warfarin (Coumadin)FDA LinkGeneric 07/2022 - 05/2003
13	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 05/2003
9	fibrin fragment D (D-dimer)IBA 01/2021 - 02/2003
8	Dalteparin (Dalteparin Sodium)FDA Link 01/2021 - 05/2003
5	Heparin (Liquaemin)FDA LinkGeneric 02/2015 - 05/2003
5	Prednisone (Sone)FDA LinkGeneric 02/2015 - 12/2004
4	Vitamin K FDA Link 10/2014 - 03/2009
3	edoxabanIBA 07/2022 - 02/2018
3	RivaroxabanIBA 11/2020 - 10/2014
3	Thalidomide (Thalomid)FDA Link 02/2015 - 12/2004
2	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 10/2018 - 12/2007
2	Fondaparinux (Arixtra)FDA Link 02/2015 - 05/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2014 - 11/2006
2	Melphalan (Alkeran)FDA LinkGeneric 02/2013 - 01/2007
2	coumarinIBA 07/2012 - 07/2003
2	AntibodiesIBA 01/2007 - 05/2003
1	factor V LeidenIBA 01/2023
1	Factor V (Coagulation Factor V)IBA 01/2023
1	Prothrombin (Factor II)IBA 01/2023
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2022
1	CreatinineIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Combined Oral ContraceptivesIBA 01/2021
1	Contraceptive Agents (Contraceptives)IBA 01/2021
1	apixabanIBA 11/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018
1	Clostridium perfringens epsilon-toxinIBA 01/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017
1	argatroban (MPQA)FDA Link 02/2015
1	danaparoid (Orgaran)FDA Link 02/2015
1	Thrombin FDA Link 02/2015
1	Sunitinib (Sutent)FDA Link 11/2014
1	AcenocoumarolIBA 10/2014
1	Enoxaparin (Lovenox)FDA LinkGeneric 10/2014
1	Lenalidomide (CC 5013)FDA Link 02/2013
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2010
1	antineoplaston A10 (A 10)IBA 07/2009
1	Genetic Markers (Genetic Marker)IBA 07/2007
1	Inflammation MediatorsIBA 07/2007
1	Immunoglobulin G (IgG)IBA 01/2007
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2007
1	Serotonin (5 Hydroxytryptamine)IBA 01/2007
1	Platelet Factor 4IBA 01/2007
1	vandetanib (ZD6474)IBA 11/2006
1	Tinzaparin (Innohep)FDA Link 04/2005
1	Imatinib Mesylate (Gleevec)FDA Link 07/2004
1	Antiphospholipid AntibodiesIBA 09/2003
1	CoumarinsIBA 07/2003
1	Inosine Triphosphate (ITP)IBA 05/2003

Therapy/Procedure

26	Therapeutics 01/2023 - 05/2003
2	Duration of Therapy 02/2018 - 03/2017
2	Drug Therapy (Chemotherapy) 02/2015 - 05/2003
1	Catheters 11/2023
1	Aftercare (After-Treatment) 01/2023
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2018
1	Stem Cell Transplantation 02/2013
1	Length of Stay 12/2012
1	Critical Care (Surgical Intensive Care) 12/2011
1	Salvage Therapy 08/2008
1	Renal Dialysis (Hemodialysis) 01/2007
1	Secondary Prevention 02/2006